URGN - urogen.com Company Cash on Hand

Official company branding of UroGen Pharma Ltd. (URGN)

UroGen Pharma Ltd. (URGN) operates a non-cyclical business where demand for bladder cancer therapy remains independent of pricing. The current cash balance confirms financial stability, and the parameter value is 0.09. While the diversification of gel platforms protects UroGen Pharma Ltd. (URGN) from research failures, challenges in promoting Jelmyto and the costs of certifying new treatment methods are weighing on overall profitability.

Company Total Cash Volume: UroGen Pharma Ltd (URGN) for 07/04/2022 - 11/21/2026

Analytical breakdowns for UroGen Pharma Ltd.

- stock value and consensus price forecast:
Fundamental valuation:URGN urogen.com
Brand item of UroGen Pharma

This metric captures the actual volume of free cash on accounts, allowing for real-time liquidity tracking between quarterly reports. For UroGen Pharma Ltd. (URGN), this capital reserve is critical when expanding the network of partner clinics; therefore, analyzing cash liquidity helps assess the company's ability to fund the commercial launch of innovative drugs without incurring new debt.

Competitors of UroGen Pharma Ltd.

Company Cash Volume ONC|HALO - Company Cash Reserve|Revolution Medicines - Company Cash on Hand|Company Cash Volume Ascentage Pharma AAPG|CGON - Company Cash Funds|Bicara Bio - Company Total Cash Amount|PSNL: Company Cash Volume|Company Cash and Cash Equivalents ERAS|Company Cash on Hand DCTH|Company Cash Reserve Y-mAbs Therapeutics Inc YMAB|Company Cash Volume AURA|CADL (Candel Therapeutics, Inc.) - Company Cash Balance|Company Cash Funds Accuray Inc ARAY|Company Liquid Assets SELLAS Life Sciences Group Inc. (SLS)|actuatetherapeutics.com - Company Cash Volume|Company Cash Reserve Citius Oncology|HURA: Company Cash Volume|Company Total Cash Volume TARA (Protara)|FATE (fatetherapeutics.com) - Company Cash Volume|Company Cash Reserve Aadi Bioscience WHWK|Company Cash Volume TCRX|CSBR - Company Cash Reserve|XBiotech - Company Cash on Hand|CEL-SCI Corporation (CVM) - Company Cash Reserve|OSTX - Company Cash Funds|Company Cash Reserve Radiopharm Theranostics Ltd|ARTV (artivabio.com) - Company Cash on Hand|ANL (Adlai Nortye Ltd) - Company Cash Funds|Company Cash on Hand VERU|Tempest Therapeutics (TPST) - Company Liquid Assets|Company Cash Volume XLO|Company Cash on Hand Renovaro RENB|Company Cash Volume MURA (Mural Oncology PLC)|KAPA - Company Cash on Hand|OnKure Therapeutics - Company Cash Volume|w2.cytomed.sg - Company Total Cash Amount|Curis Corp (CRIS) - Company Cash Funds|Company Cash Reserve Apollomics Corp (APLM)|Company Cash Funds Tharimmune|Company Cash Volume advanbiomed.com|Company Cash Funds Genprex, Inc (GNPX)|Company Liquid Assets Calidi Biotherapeutics, Inc.|Company Cash Volume SBFM (Sunshine Biopharma Inc.)|XBIO - Company Cash on Hand|SLRX: Company Cash on Hand|Company Cash Balance PPBT (Purple Biotech Ltd.)|AONC: Company Cash Volume|Company Cash Reserve BeOne Medicines (BGNE)|Company Cash Funds Checkpoint Therapeutics, Inc.|Company Cash on Hand Elevation Oncology (ELEV)|Company Cash Funds iCAD Corp (ICAD)|Company Cash on Hand Ikena IKNA|Company Cash Volume NTBL (notablelabs.com)|VIRX - Company Cash on Hand|MOR: Company Cash on Hand|NAYA - Company Cash Volume|Ascentage Pharma (AAPGV) - Company Cash Funds